Skip to main content

Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention (e.g. for symptomatic relief). Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials.

Vascular disease is a complex field with primary care physicians and nurse practitioners as well as several specialties involved. The latter include cardiology, vascular and cardio thoracic surgery, general medicine, radiology, clinical pharmacology and neurology (stroke units). Current Vascular Pharmacology will publish reviews to update all those concerned with the treatment of vascular disease. For example, reviews commenting on recently published trials or new drugs will be included. In addition to clinically relevant topics we will consider 'research-based' reviews dealing with future developments and potential drug targets. Therefore, another function of Current Vascular Pharmacology is to bridge the gap between clinical practice and ongoing research.

Debates will also be encouraged in the correspondence section of this journal.

Publisher: Bentham Science Publishers

Volume 7, Number 4, October 2009

Articles

Nucleoside Transporter Proteins
pp. 426-434(9)
Authors: Molina-Arcas, Miriam; Casado, F. J.; Pastor-Anglada, Marcal

Favourites:
ADD

Equilibrative Nucleoside Transporters in Fetal Endothelial Dysfunction in Diabetes Mellitus and Hyperglycaemia
pp. 435-449(15)
Authors: Westermeier, Francisco; Puebla, Carlos; Vega, Jose L.; Farias, Marcelo; Escudero, Carlos; Casanello, Paola; Sobrevia, Luis

Favourites:
ADD

Do Adenosine Receptors Offer New Therapeutic Options for Diabetic Nephropathy?
pp. 450-459(10)
Authors: Martin, Rody S.; Valladares, Denisse; Roa, Horacio; Troncoso, Evelin; Sobrevia, Luis

Favourites:
ADD

Insulin Action on the Human Placental Endothelium in Normal and Diabetic Pregnancy
pp. 460-466(7)
Authors: Hiden, Ursula; Lang, Ingrid; Ghaffari-Tabrizi, Nassim; Gauster, Martin; Lang, Uwe; Desoye, Gernot

Favourites:
ADD
Favourites:
ADD

Potential Cell Signalling Mechanisms Involved in Differential Placental Angiogenesis in Mild and Severe Pre-Eclampsia
pp. 475-485(11)
Authors: Escudero, Carlos; Puebla, Carlos; Westermeier, Francisco; Sobrevia, Luis

Favourites:
ADD

Dysfunctions of the Diffusional Membrane Pathways Mediated Hemichannels in Inherited and Acquired Human Diseases
pp. 486-505(20)
Authors: Schalper, Kurt A.; Orellana, Juan A.; Berthoud, Viviana M.; Saez, Juan C.

Favourites:
ADD

Regulation of the Sodium-Phosphate Cotransporter Pit-1 and its Role in Vascular Calcification
pp. 506-512(7)
Authors: Gonzalez, Magdalena; Martinez, Rafael; Amador, Cristian; Michea, Luis

Favourites:
ADD

Epigenetics: New Concepts of Old Phenomena in Vascular Physiology
pp. 513-520(8)
Authors: Krause, Bernardo; Sobrevia, Luis; Casanello, Paola

Favourites:
ADD

The Role of Trophoblast Nutrient and Ion Transporters in the Development of Pregnancy Complications and Adult Disease
pp. 521-533(13)
Authors: Jansson, Thomas; Myatt, Leslie; Powell, Theresa L.

Favourites:
ADD

Glucose Transporters in Sex Steroid Hormone Related Cancer
pp. 534-548(15)
Authors: Nualart, Francisco; Garcia, Maria de los Angeles; Medina, Rodolfo A.; Owen, Gareth I.

Favourites:
ADD

HDL Therapy for the Treatment of Cardiovascular Diseases
pp. 550-556(7)
Authors: Parolini, Cinzia; Marchesi, Marta; Chiesa, Giulia

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more